Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-004029
Filing Date
2021-08-20
Accepted
2021-08-20 21:14:14
Documents
1
Period of Report
2021-08-19

Document Format Files

Seq Description Document Type Size
1 form4-08202021_060804.html 4  
1 form4-08202021_060804.xml 4 4595
  Complete submission text file 0001415889-21-004029.txt   5963
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Harmon Cyrus (Reporting) CIK: 0001831410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 211195138